🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc. logo
Market Cap: Low
Employees: Low

Probody technology platform

Cytom X Therapeutics, Inc. is an oncology-focused biopharmaceutical company that develops antibody therapeutics based on its Probody technology platform for treating cancer. Its product candidates include CX-2009, CX-2029, BMS-986249, BMS-986288, CX-2043, and CX-904, targeting various cancers and currently in clinical trials.

Tags: antibody therapeutics, biopharmaceuticals, cancer treatment, clinical trials, oncology

Symbol: CTMX

Recent Price: $1.02

Industry: Biotechnology

CEO: Dr. Sean A. McCarthy DPHIL

Sector: Healthcare

Employees: 120

Address: 151 Oyster Point Boulevard, South San Francisco, CA 94080

Phone: 650 515 3185

Last updated: 2024-12-31